Amedeo Smart

Free Medical Literature Service

 

Amedeo

Hypertension
  Free Subscription

Articles published in
Curr Opin Nephrol Hypertens
    March 2026
  1. WHELTON PK, O'Connell S, Mills K
    Evolution in the targets for blood pressure treatment.
    Curr Opin Nephrol Hypertens. 2026;35:141-149.
    >> Share

  2. WEHBE F, Hiremath S
    Cuffless blood pressure in 2025: from promise to practice: a narrative review.
    Curr Opin Nephrol Hypertens. 2026;35:164-173.
    >> Share

    January 2026
  3. SAXENA M, He FJ, Caulfield MJ
    New pharmacological therapies for hypertension.
    Curr Opin Nephrol Hypertens. 2026 Jan 23. doi: 10.1097/MNH.0000000000001163.
    >> Share

  4. GUPTA R
    Managing hypertension and cardiovascular risk in resource-limited settings.
    Curr Opin Nephrol Hypertens. 2026 Jan 20. doi: 10.1097/MNH.0000000000001161.
    >> Share

  5. O'CONNELL SS, Whelton PK, Mills KT
    Global trends in hypertension prevalence, awareness, treatment, and control.
    Curr Opin Nephrol Hypertens. 2026 Jan 7. doi: 10.1097/MNH.0000000000001151.
    >> Share

  6. TANTIRIGE NN, Gray JM, Wilkinson IB
    Hypertension guidelines need to be patient oriented.
    Curr Opin Nephrol Hypertens. 2026 Jan 6. doi: 10.1097/MNH.0000000000001154.
    >> Share

  7. HASELER E, Sinha MD
    Tackling the epidemic of obesity and hypertension in children and young people.
    Curr Opin Nephrol Hypertens. 2026 Jan 6. doi: 10.1097/MNH.0000000000001156.
    >> Share

  8. DHERANI M, Wagner SK, Shantsila E
    The role of artificial intelligence in hypertension management.
    Curr Opin Nephrol Hypertens. 2026 Jan 6. doi: 10.1097/MNH.0000000000001157.
    >> Share

  9. TANTISATTAMO E, Rattanasompattikul M, Traitanon O, Eguchi N, et al
    Enhancing accuracy and adherence in blood pressure monitoring in living kidney donation: implementing technologies to overcome challenges.
    Curr Opin Nephrol Hypertens. 2026;35:43-51.
    >> Share

    December 2025
  10. HERNANDEZ MF, Chang TI
    Pros and cons of lower blood pressure targets in chronic kidney disease.
    Curr Opin Nephrol Hypertens. 2025 Dec 30. doi: 10.1097/MNH.0000000000001153.
    >> Share

    July 2025
  11. BOURDON F, Ponte B, Dufey Teso A
    The impact of sex on blood pressure.
    Curr Opin Nephrol Hypertens. 2025;34:322-329.
    >> Share

    May 2025
  12. ROSSI GP, Bagordo D, Rossi FB
    Rethinking arterial hypertension: the need for a paradigm shift.
    Curr Opin Nephrol Hypertens. 2025;34:259-266.
    >> Share

  13. HUANG JX, Peschard VG, Ku E
    Impact of intensive blood pressure control on kidney outcomes.
    Curr Opin Nephrol Hypertens. 2025;34:224-231.
    >> Share

    April 2025
  14. COPUR S, Burlacu A, Kanbay M
    Novel approaches in antihypertensive pharmacotherapeutics.
    Curr Opin Nephrol Hypertens. 2025 Apr 23. doi: 10.1097/MNH.0000000000001081.
    >> Share

    November 2024
  15. TANTISATTAMO E, Ferrey AJ, Reddy UG, Redfield RR 3rd, et al
    Diagnostic and therapeutic challenges in implementing hypertension management after kidney transplantation.
    Curr Opin Nephrol Hypertens. 2024 Nov 11. doi: 10.1097/MNH.0000000000001045.
    >> Share

  16. TAAL MW
    Optimizing kidney and cardiovascular protection in an era of multiple effective treatments.
    Curr Opin Nephrol Hypertens. 2024;33:551-556.
    >> Share

    September 2024
  17. ABDELLATIF DA
    Social and humanitarian issues in nephrology and hypertension.
    Curr Opin Nephrol Hypertens. 2024 Sep 12. doi: 10.1097/MNH.0000000000001026.
    >> Share

    June 2024
  18. TUTTLE M, Sarnak MJ, Navaneethan SD
    Therapeutic approaches for pulmonary hypertension in patients with chronic kidney disease.
    Curr Opin Nephrol Hypertens. 2024 Jun 20. doi: 10.1097/MNH.0000000000001008.
    >> Share

    May 2024
  19. BANSAL S
    Revisiting resistant hypertension in kidney disease.
    Curr Opin Nephrol Hypertens. 2024 May 13. doi: 10.1097/MNH.0000000000001002.
    >> Share

    April 2024
  20. DISSANAYAKE LV, Palygin O, Staruschenko A
    Lysine and salt-sensitive hypertension.
    Curr Opin Nephrol Hypertens. 2024 Apr 22. doi: 10.1097/MNH.0000000000000994.
    >> Share

    March 2024
  21. AL-HOSNI R, Kaye R, Choi CS, Tammaro P, et al
    The TMEM16A channel as a potential therapeutic target in vascular disease.
    Curr Opin Nephrol Hypertens. 2024;33:161-169.
    >> Share

    January 2024
  22. DEMIRCI M, Hinton A, Kirabo A
    Dendritic cell epithelial sodium channel induced inflammation and salt-sensitive hypertension.
    Curr Opin Nephrol Hypertens. 2024 Jan 8. doi: 10.1097/MNH.0000000000000963.
    >> Share

  23. BENSON LN, Mu S
    Interferon gamma in the pathogenesis of hypertension - recent insights.
    Curr Opin Nephrol Hypertens. 2024 Jan 5. doi: 10.1097/MNH.0000000000000966.
    >> Share

  24. ALVAREZ-ELIAS AC, Brenner BM, Luyckx VA
    Climate change and its influence in nephron mass.
    Curr Opin Nephrol Hypertens. 2024;33:102-109.
    >> Share

    November 2023
  25. TANTISATTAMO E, Ferrey AJ, Reddy UG, Malik FT, et al
    A paradigm shift from office to home-based blood pressure measurement approaches in kidney transplant recipients.
    Curr Opin Nephrol Hypertens. 2023 Nov 9. doi: 10.1097/MNH.0000000000000951.
    >> Share

  26. LUCAS B, Taal MW
    Blood pressure targets in chronic kidney disease: still no consensus.
    Curr Opin Nephrol Hypertens. 2023;32:497-501.
    >> Share

    September 2023
  27. CAMAFORT M, Ihm SH, Ruilope LM
    Renal denervation for the treatment of hypertension and kidney disease.
    Curr Opin Nephrol Hypertens. 2023 Sep 14. doi: 10.1097/MNH.0000000000000928.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016